FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 312:823-827 March 28, 1985 Number 13 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Plasma potassium rises during muscular exercise and falls rapidly when exercise is stopped. Since the sympathoadrenal system is stimulated with exertion and both alpha- and beta-adrenergic agonists affect internal potassium homeostasis, we studied the influence of catecholamines on potassium shifts during and after exercise. Six healthy subjects were given maximal exercise stress tests under three conditions: with no medication (control), during beta-blockade with propranolol, and during alpha-blockade with phentolamine. Compared with a peak rise in plasma potassium of 1.23 +/- 0.27 mmol per liter (mean +/- S.E.M.) during the control study, propranolol caused a rise of 1.89 +/- 0.35 (P less than 0.01) and a sustained elevation during recovery. Phentolamine diminished the rise of potassium (0.70 +/- 0.21 mmol per liter; P less than 0.01) and lowered the potassium level throughout recovery. These effects of catecholamines were independent of the venous pH, the plasma bicarbonate and serum glucose levels, and urinary potassium excretion, and they did not appear to be due to insulin. High norepinephrine and epinephrine levels confirmed the release of catecholamines capable of stimulating alpha- and beta-receptors. Exercise work did not differ among the groups. beta-Adrenergic receptors appear to moderate the acute hyperkalemia of exercise, whereas alpha-adrenergic receptors act to enhance hyperkalemia and may protect against hypokalemia when exertion ceases.

This article has been cited by other articles:

• Hawboldt, J., McGrath, D. (2006). Possible Metoprolol-Induced Hyperkalemia. Journal of Pharmacy Practice 19: 320-325 [Abstract]  
• Evans, K. J., Greenberg, A. (2005). Hyperkalemia: A Review. J Intensive Care Med 20: 272-290 [Abstract]  
• CLAUSEN, T. (2003). Na+-K+ Pump Regulation and Skeletal Muscle Contractility. Physiol. Rev. 83: 1269-1324 [Abstract] [Full Text]  
• Geleijnse, M. L., Elhendy, A., Fioretti, P. M., Roelandt, J. R. T. C. (2000). Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 36: 2017-2027 [Abstract] [Full Text]  
• Doshi, S. K., Singh, B. N. (2000). Reviews: Pure Class III Antiarrhythmic Drugs: Focus on Dofetilide. J CARDIOVASC PHARMACOL THER 5: 237-247  
• Botker, H. E., Sonne, H. S., Frobert, O., Andreasen, F. (1999). Enhanced exercise-induced hyperkalemia in patients with syndrome X. J Am Coll Cardiol 33: 1056-1061 [Abstract] [Full Text]  
• Demolis, J.-L., Funck-Brentano, C., Ropers, J., Ghadanfar, M., Nichols, D. J., Jaillon, P. (1996). Influence of Dofetilide on QT-Interval Duration and Dispersion at Various Heart Rates During Exercise in Humans. Circulation 94: 1592-1599 [Abstract] [Full Text]  
• Williams, M. E., Rosa, R. M. (1988). Hyperkalemia: Disorders of Internal and External Potassium Balance. J Intensive Care Med 3: 52-64 [Abstract]